Indapamide
8 NDCs across 3 manufacturers|8 Generic,0 Brand
Indapamide is used to treat edema, heart failure, hypertension and nephrotic syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 6, 1983, and the first generic was approved Jul 27, 1995. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $5 million on Indapamide across 371,000 claims for 97,000 beneficiaries.
Indapamide is available as 8 NDCs from 3 manufacturers (8 generic, 0 brand), with NADAC prices from $0.11 to $0.11 per EA — a 1% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
8
8G / 0B
Manufacturers
3
competing in market
Price Spread
$0.11 – $0.11
per EA
7d Activity
avg -0.6% WoW · of 8 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Actavis Pharma, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Thiazide-like Diuretic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing INDAPAMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
INDAPAMIDE 1.25 MG TABLET | $0.1087 per EA | +1.87% |
INDAPAMIDE 1.25 MG TABLET | $0.1087 per EA | +1.87% |
INDAPAMIDE 1.25 MG TABLET | $0.1087 per EA | +1.87% |
INDAPAMIDE 1.25 MG TABLET | $0.1087 per EA | +1.87% |
INDAPAMIDE 2.5 MG TABLET | $0.1076 per EA | -3.04% |
INDAPAMIDE 2.5 MG TABLET | $0.1076 per EA | -3.04% |
INDAPAMIDE 2.5 MG TABLET | $0.1076 per EA | -3.04% |
INDAPAMIDE 2.5 MG TABLET | $0.1076 per EA | -3.04% |
Frequently Asked Questions
What is Indapamide used to treat?
Indapamide is used to treat edema, heart failure, hypertension and nephrotic syndrome, per the National Library of Medicine's MED-RT classification.
When did Indapamide become available as a generic?
FDA approved the first generic Indapamide (ANDA) on Jul 27, 1995. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Indapamide?
In 2024, Medicare Part D spent $5 million on Indapamide across 371,000 claims for 97,000 beneficiaries.
How many Indapamide products are on the market?
The Indapamide drug market contains 8 NDCs from 3 manufacturers — 8 generic and 0 brand products.
What is the price range for Indapamide?
NADAC reference prices for Indapamide range from $0.1076 to $0.1087 per EA — a 1% difference between cheapest and most expensive.
Which manufacturers make Indapamide?
3 manufacturers list Indapamide in NADAC. Ranked by number of NDCs, the largest are Actavis Pharma, Inc. (4), Rising Pharma Holdings Inc. (2), ANI Pharmaceuticals, Inc. (2).
How has the price of Indapamide changed recently?
Over the past 7 days, 4 Indapamide NDCs rose and 4 fell, with a market-wide average change of -0.6%.